🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Curtis J. Perry

Yale Cancer Center

ORCID: 0000-0003-3715-5332

Also affiliated with Yale University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.

101 citations

Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia Jilaveanu +17 more

81 citations

Bao Wang, Jessica Wei, Antonio H. de O. Fonseca, Curtis J. Perry, Alexander Frey +6 more

1 citations

Katie Liu, Ryan Liu, Gautham Ramshankar, Curtis J. Perry, Rachel J. Perry +1 more

1 citations

Katie Liu, Ryan Liu, Gautham Ramshankar, Curtis J. Perry, Rachel J. Perry +1 more

1 citations

Kathryn Clulo, Yuewei Fei, Therese Cordero Dumit, Frankie Scallo, Jerry William Allen +12 more

0 citations

Alexander Frey, Yuewei Fei, Philippos Apolinário Costa, Jason Z Wang, Sina Ghadermarzi +11 more